July 1, 2018Open Access

Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Colorectal cancer (CRC) is the fourth most frequently diagnosed cancer and the second leading cause of cancer death in the United States. In 2018, an estimated 43,030 new cases of rectal cancer will occur in the United States (25,920 cases in men; 17,110 cases in women), and an estimated 50,630 people will die from rectal and colon cancer combined. 1 Despite

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Benson et al. (Sun,) studied this question.

synapsesocial.com/papers/69dd39680a7b4bc8c4100fe5 https://doi.org/https://doi.org/10.6004/jnccn.2018.0061

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Multidisciplinary management of resectable rectal cancer.1996 · 46 citations
2The TME Trial After a Median Follow-up of 6 Years2007 · 1,196 citations
3The role of diffusion-weighted MRI and 18F-FDG PET/CT in the prediction of pathologic complete response after radiochemotherapy for rectal cancer: A systematic review2014 · 200 citations
4Neoadjuvant Chemotherapy Without Routine Use of Radiation Therapy for Patients With Locally Advanced Rectal Cancer: A Pilot Trial2014 · 424 citations
5Pre-operative chemoradiation for non-metastatic locally advanced rectal cancer2012 · 169 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo